SCHEMBL12788508

SCHEMBL12788508

Cc1nc2ccc(N(C)CCc3ccccc3)cc2c(=O)n1C(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 3/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ IP6K1 Q92551 1/20 0.39
▸ MAOB P27338 1/20 0.38
▸ KDM4C Q9H3R0 1/20 0.38
▸ GFER P55789 1/20 0.35
▸ ABCC1 P33527 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12788544 0.95 DHFR (0.41) DHFRMEN1KMT2AIP6K1MAOB
SCHEMBL12788906 0.89 NTSR1 (0.40) DHFRMEN1KMT2AIP6K1ALDH1A1
SCHEMBL12788421 0.89 IP6K1 (0.50) DHFRMEN1KMT2AIP6K1KDM4C
SCHEMBL12846932 0.87 DHFR (0.39) DHFRMEN1KMT2AIP6K1ALDH1A1
SCHEMBL13564458 0.86 DHFR (0.39) DHFRIP6K1ALDH1A1KDM4EHPGD
SCHEMBL12788909 0.85 DHFR (0.36) DHFRIP6K1ALDH1A1KDM4EHPGD
SCHEMBL12788953 0.85 NAMPT (0.38) DHFRMEN1KMT2AIP6K1ALDH1A1
SCHEMBL12789902 0.85 DHFR (0.36) DHFRIP6K1ALDH1A1KDM4EHPGD
SCHEMBL12788332 0.84 PDE3B (0.46) DHFRIP6K1ALDH1A1KDM4EMAPK1
SCHEMBL12788945 0.84 DHFR (0.35) DHFRIP6K1ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297117-B1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME (US) 2012-10-31 — — EP disclosed
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME CORP. 2011-03-17 — — US disclosed
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS MERCK SHARP & DOHME CORP. 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065671-A1 BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS GPR119, GPR39, GPR65 DHFR 3231/4885MEN1 3069/4885KMT2A 3444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback